Publications by authors named "Thomas Gillis"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

364,632

Total Likes

12,282

Extended Reach

1,678,592

Social Features

111
G
Gradient Myopic Defocus Causes Chick Scleral Tissue Reinforcement and Structural Scleral Remodeling.
Denise Hileeto, Thomas Gillis, Elizabeth Irving

Curr Eye Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An orthogonal T7 replisome for continuous hypermutation and accelerated evolution in .
Christian S Diercks, Philipp Sondermann, Cynthia Rong, Thomas G Gillis, Yahui Ban

Science· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computation-guided redesign of promoter specificity of a bacterial RNA polymerase.
Xiangyang Liu, Anthony T Meger, Thomas Gillis, Jonah O'Mara Schwartz, Balendra Sah

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Orthogonal T7 Replisome for Continuous Hypermutation and Accelerated Evolution in .
Christian S Diercks, Philipp J Sondermann, Cynthia Rong, David A Dik, Thomas G Gillis

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A parameterized two-domain thermodynamic model explains diverse mutational effects on protein allostery.
Zhuang Liu, Thomas G Gillis, Srivatsan Raman, Qiang Cui

Elife· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A parametrized two-domain thermodynamic model explains diverse mutational effects on protein allostery.
Zhuang Liu, Thomas Gillis, Srivatsan Raman, Qiang Cui

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the 5'-Triphosphate Metabolites of Ribavirin, Sofosbuvir, Vidarabine, and Molnupiravir on CTP Synthase Catalysis and Filament Formation: Implications for Repurposing Antiviral Agents against SARS-CoV-2.
Thomas D Gillis, Stephen L Bearne

ChemMedChem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular investigation of the tandem Tudor domain and plant homeodomain histone binding domains of the epigenetic regulator UHRF2.
Shane M Ginnard, Alyssa E Winkler, Carlos Mellado Fritz, Tatum Bluhm, Ray Kemmer, Thomas Gillis

Proteins· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of infection.
Malcolm S Duthie, Maria T Pena, Gigi J Ebenezer, Thomas P Gillis, Rahul Sharma

NPJ Vaccines· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of infection.
Malcolm S Duthie, Maria T Pena, Gigi J Ebenezer, Thomas P Gillis, Rahul Sharma

NPJ Vaccines· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitazoxanide is active against Mycobacterium leprae.
Mai Ann Bailey, Hana Na, Malcolm S Duthie, Thomas P Gillis, Ramanuj Lahiri

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection.
Colin M Dinney, Lu-Dong Zhao, Charles D Conrad, Jay M Duker, Richard O Karas, Thomas R Gillis

J Microbiol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current knowledge on Mycobacterium leprae transmission: a systematic literature review.
Martin W Bratschi, Peter Steinmann, Anna Wickenden, Thomas P Gillis

Lepr Rev· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symposium Report: Developing Strategies to Block the Transmission of Leprosy.
Deborah Mensah-Awere, Martin W Bratschi, Peter Steinmann, Jessica K Fairley, Thomas P Gillis

Lepr Rev· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B.
Thomas P Gillis, Michael V Tullius, Marcus A Horwitz

Infect Immun· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice.
Grace L Davis, Nashone A Ray, Ramanuj Lahiri, Thomas P Gillis, James L Krahenbuhl

PLoS Negl Trop Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug resistance in patients with leprosy in the United States.
Diana L Williams, Cheryl Lewis, Felipe G Sandoval, Naoko Robbins, Stephen Keas, Thomas P Gillis

Clin Infect Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-resistant leprosy: monitoring and current status.
Diana L Williams, Thomas P Gillis

Lepr Rev· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances and hurdles on the way toward a leprosy vaccine.
Malcolm S Duthie, Thomas P Gillis, Steven G Reed

Hum Vaccin· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the evidence that the putative Mycobacterium lepromatosis species causes diffuse lepromatous leprosy?
Thomas P Gillis, David M Scollard, Diana N J Lockwood

Lepr Rev· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hansen's disease (leprosy) complicated by secondary mycobacterial infection.
David M Scollard, Barbara M Stryjewska, John F Prestigiacomo, Thomas P Gillis, Jennifer Waguespack-Labiche

J Am Acad Dermatol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.
Vanitha S Raman, Joanne O'Donnell, H Remy Bailor, Wakako Goto, Ramanuj Lahiri, Thomas P Gillis

Infect Immun· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of short tandem repeats for genotyping Mycobacterium leprae.
Thomas Gillis, Varalakshmi Vissa, Masanori Matsuoka, Saroj Young, Jan Hendrik Richardus

Lepr Rev· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of high level pseudogene transcription in Mycobacterium leprae.
Diana L Williams, Richard A Slayden, Amol Amin, Alejandra N Martinez, Tana L Pittman, Thomas P Gillis

BMC Genomics· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis